Orthopedics This Week

Spineology Announces New OptiMesh® TLIF System, Expanding Surgical Access and Procedural Versatility

New system enhances the OptiMesh platform, giving surgeons greater flexibility to incorporate expandable implant technology into their preferred TLIF approach.

RESTEM Receives FDA Clearance of IND for Phase 1/2 Clinical Trial of Restem-X in Knee Osteoarthritis

Phase 1/2 clinical trial anticipated to be initiated in the first half of 2027.

Advita Ortho Expands Global Reach of Vantage® Total Ankle System with First Surgeries in Japan

Advita Ortho today announced first surgeries in Japan using the Vantage® Total Ankle Fixed Bearing System, including the Activit-E® polyethylene liner.

CONMED Trims Its Portfolio and Finds Growth in Orthopedics

CONMED’s third-quarter report comes with a small trap for anyone who reads only the headline.

Axogen Shows Its Nerve as Sales Climb 26 Percent

Axogen’s 26% sales jump is great, but will acquiring BioCircuit make it even higher?

Gives the Interscalene Block Some Competition

A randomized trial in The Journal of Bone and Joint Surgery pits two pain management techniques against each other.

OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System Successful Limited Launch Highlights Strong Demand and Adoption of the Company’s Innovative Early Onset Scoliosis Solution

Spinal Cord Decompression Gets a Stronger Case for Speed

Is faster decompression of a spinal cord trauma ALWAYS better?

Stryker Delivers Growth and a Reality Check

An uncharacteristically difficult quarter for Stryker, which for most other companies would be a great quarter.

Porous Titanium Screws Show Staying Power in Elderly Pelvic Injuries

Is 18% implant migration versus 0% a clear enough signal?

Onkos Surgical Continues Expansion of NanoCept® Antibacterial Technology with Latest FDA Clearance

Onkos Surgical announced a new FDA 510(k) clearance for its NanoCept Antibacterial Technology, expanding its application to a broader offering of titanium components in the ELEOS Limb Salvage System.

What Happens When You Put Something Between Conservative Care and Surgery

Vivex matched 1,804 Medicare patients treated with VIA Disc NP against 1,804 managed with conservative care. Opioid supply, imaging, injections, and physical therapy all dropped in the year after the procedure. Chief Clinical Officer Jon Block, Ph.D., walks through what the data show and what the company is studying next.